38 employees
Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics.
2021
$30M
from 1 investors over 1 rounds
Vector BioPharma raised $30M on August 10, 2022
Investors: Versant Ventures